Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

MDExam vs NativeMed

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.1

MDExam

Best for mainstream telehealth GLP-1 access
★★★3.6
SemaglutideTirzepatide
Visit MDExam
7.1

NativeMed

Best for buyers comfortable with sub-$200 promotional compounded GLP-1 pricing who can verify pharmacy partner identity directly with NativeMed support before subscribing
★★★3.6

Starting at $149/mo

Compounded SemaglutideCompounded TirzepatideLegitScript CertifiedCash Pay
Visit NativeMed

Side-by-Side Comparison

FeatureMDExamNativeMed
Overall Score7.1/107.1/10
Starting Price$149/mo
Editorial Rating3.6 ★ /53.6 ★ /5
Features2 features4 features
States Available00
Compounded✓ Yes
Brand Name
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

MDExam

Pros

  • Both semaglutide and tirzepatide available

Cons

  • Pricing not publicly disclosed

NativeMed

Pros

  • LegitScript certified per the homepage footer (independently verifiable)
  • Promotional pricing publicly displayed: $149/mo semaglutide, $183/mo tirzepatide (sale from $299/$399 regular)
  • Async questionnaire workflow with synchronous visit triggered when state law requires it

Cons

  • Pharmacy partners are NOT publicly named — material gap for YMYL disclosure (described only as 'USA-based pharmacies' / 'accredited pharmacies')
  • States served list is not publicly enumerated
  • Pricing displayed as promotional sale price — readers should confirm whether the $149/$183 holds beyond the first month or escalates to the $299/$399 'regular' price
  • Trustpilot reviews displayed on homepage — we do NOT cite Trustpilot as a primary source per editorial policy

Our Verdict

Both MDExam and NativeMed score equally well overall — the right choice depends on your priorities. Choose MDExam if you want mainstream telehealth GLP-1 access, or NativeMed if buyers comfortable with sub-$200 promotional compounded GLP-1 pricing who can verify pharmacy partner identity directly with NativeMed support before subscribing matters most to you.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.